Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “antagonist”

678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 678
Index total 30,257
Page 21 / 29

Quick answer

This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

678 results for “antagonist” · 30,257 patents in full index Clear search

  1. US 7910621

    Small molecule antagonists of XIAP family proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  2. US 7910608

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  3. US 7902221

    Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  4. US 7902220

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  5. US 7884091

    Methods for treating delirium using glucocorticoid receptor-specific antagonists

    Corcept Therapeutics Incorporated · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  6. US 7879838

    Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity

    Pharmacopeia Drug Discovery, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  7. US 7875637

    Benzimidazole derivative and use as a II receptor antagonist

    Takeda Pharmaceutical Company Limited · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  8. US 7868175

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  9. US 7868006

    Heterocyclic substituted piperazines with CXCR3 antagonist activity

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  10. US 7858795

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  11. US 7858797

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  12. US 7858792

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  13. US 7855202

    Imidazopyridine derivatives as A2B adenosine receptor antagonists

    Laboratories Almirall, S.A. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

  14. US 7851631

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

  15. US 7850961

    Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

  16. US 7851632

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

  17. US 7842704

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  18. US 7842686

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  19. US 7838535

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  20. US 7834000

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted

  21. US 7834185

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted

  22. US 7820154

    Use of IL-1 antagonists to treat gout

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  23. US 7816532

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  24. US 7807164

    Lyophilized VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.